Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
LY3972406 Dose 2 for Plaque Psoriasis Clinical Trial 2024 | Power
A Study of LY3972406 in Adult Participants With Moderate-to-Severe ...
LY3437943，一种用于血糖控制和减肥的新型胰高血糖素、GIP 和 GLP-1 受体激动剂：从发现到临床概念验证,Cell ...
eltrekibart (LY3041658) / Eli Lilly
LY4268989 / Schrodinger, Eli Lilly
LY-364947 | Cell Signaling Technology
LY3009120 |CAS:1454682-72-4 Probechem Biochemicals
Ly3298176 – Application in Therapy and Current Clinical Research
Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley ...
Hybrid meeting divulges structures of drug candidates
New drug candidates shine in San Diego
Structure and Properties of Gelatin | Encyclopedia MDPI
The chemical structure of LY2606368. | Download Scientific Diagram
LY3298176 Lowers Body Weight in Obese Mice. The starting body weight of ...
Discovery of a Small Molecule Probe That Post-Translationally ...
礼来终止开发4个临床项目医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Frontiers | Selection of lansoprazole from an FDA-approved drug library ...
Latest psoriasis Research Papers/Journal Articles | DovePress
Inhibition of lysosomal phospholipase A2 predicts drug-induced ...
Therapeutic Development Based on the Immunopathogenic Mechanisms of ...
Natural Product-Derived Compounds Targeting Keratinocytes and Molecular ...
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor ...
Pharmaco-Omics in Psoriasis: Paving the Way towards Personalized Medicine
Nanoscale Topical Pharmacotherapy in Management of Psoriasis ...
New and Emerging Biological and Oral/Topical Small-Molecule Treatments ...
Topical Delivery for Psoriasis Therapy | IJN
Frontiers | Current evidence on the role of lipid lowering drugs in the ...
Psoriasis - The Lancet
Targeted Therapy Development in Acute Myeloid Leukemia
A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and ...
Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral ...
Eli Lilly H1 2025: Tirzepatide Drives 41% Revenue Surge as 4 Clinical ...
ACS Medicinal Chemistry Letters Vol. 15 No. 2 - ACS Publications
Sino Biopharm’s Oral Psoriasis Drug TQH3906 Delivers Biologic-Like ...
TYK2 in Autoimmunity and Treatment of Psoriasis | JIR
Recent advances in the pharmacology of voltage-gated ion channels ...
Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics | IJN ...
PDE4 inhibitor LY2775240,... | Download Scientific Diagram
Compounds currently approved or undergoing clinical trials for cancer ...
Pharmaceuticals | April 2021 - Browse Articles
(PDF) LY3298176, A Novel Dual GIP And GLP-1 Receptor Agonist For The ...
WO2012150892A1 - Treatment of psoriasis - Google Patents
The Parallel Structure–Activity Relationship Screening of Three ...
Discovery and characterization of LY2784544, a small-molecule tyrosine ...
Psoriasis « New Drug Approvals
Molecular Pharmaceutics | Vol 4, No 5
A Computational Approach for Identifying Experimental or Approved Drugs ...
Journal of Medicinal Chemistry Vol. 66 No. 21 - ACS Publications
Enhanced Anti-Cancer Potential: Investigating the Combined Effects with ...
New Treatment Addressing the Pathogenesis of Psoriasis
Treatment with the triple-drug combination (LY294002, PLX4720 and ...
Design, synthesis, docking study and anticancer evaluation of new ...
Nanoparticles of a Pyrazolo-Pyridazine Derivative as Potential EGFR and ...
Elucidating Drug-Enzyme Interactions and Their Structural Basis for ...
Characterization of LY2775240, a selective phosphodiesterase‐4 ...
Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and ...
LY2606368, with or without cisplatin, causes significant tumor ...
Self-Assembling Enzymatic Nanocomplexes with Polypeptides and Low ...
e Pharmacokinetics of LY3298176. | Download Table
(PDF) LY2439821, a humanized anti-interleukin-17 monoclonal antibody ...
Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability ...
A Route for Investigating Psoriasis: From the Perspective of the ...
Pharmaceutics | Special Issue : Current and Emerging Biological and ...
Literature based validated drugs shown to have anti-psoriasis activity ...
Study Demonstrates Efficacy of Topical PF-07038124 in Treating Atopic ...
Immunomodulatory Effect of Methotrexate Abruptly Controls Keratinocyte ...
Innovative Approaches to Psoriasis: Small Molecules Targeting Key ...
In Vitro and Human Pilot Studies of Different Topical Formulations ...
Novartis Molecule « New Drug Approvals
Design, Synthesis, In Vitro Anticancer Evaluation and Molecular ...
Experimental Pharmacological Management of Psoriasis - PMC
LY2439821, a humanized anti–interleukin‐17 monoclonal antibody, in the ...
Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 ...
Entry into a New Class of Potent Proteasome Inhibitors Having High ...
Neuroprotective Effects of LY379268, a Selective mGlu2/3 Receptor ...
Lipid based nanoparticles in clinical trials. | Download Scientific Diagram
Life Science News: New Psoriasis Treatment Breakthrough | Patsnap
LY4101174 / Eli Lilly
In Defense of Secondary Pharmaceutical Patents in Drug Discovery and ...
Biochemistry and Diseases Related to the Interconversion of ...
Lipid-based nanoparticles for psoriasis treatment: a review on ...
FDA approved drugs for the treatment of psoriasis. | Download ...
Topical Therapy in Psoriasis: Clinical Benefits, Advances in Novel Drug ...
LY 362884 | Semantic Scholar
Phytochemical and pharmacoinformatics analysis of a traditional ...
Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs
Pharmaceuticals | Free Full-Text | 29th Annual GP2A Medicinal Chemistry ...
Structural hybridization of some preclinical and clinical anticancer ...
Frontiers | The Natural Polypeptides as Significant Elastase Inhibitors
LY-339476-药物合成数据库
Antimicrobial peptides in the pathogenesis of psoriasis - PMC
Psoriasis trials: a summary of clinical trials of targeted therapy for ...
First-Time-in-Human Study and Prediction of Early Bactericidal Activity ...
Review of natural compounds for potential psoriasis treatment - PMC
Three-Dimensional Quantitative Structure-Activity Relationships of ...
Inhibit or Evade Multidrug Resistance P-glycoprotein in Cancer ...
Identifying Herbal Candidates and Active Compounds for Psoriasis ...
GlpBio - Master of Bioactive Molecules | Compound Libraries, Inhibitors ...
Frontiers | Efficacy and safety of mirikizumab (LY3074828) in chronic ...
Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody ...
| PTT | Dove Medical Press
A phase 1b open-label study to evaluate the safety, tolerability ...
Targeting epigenetic modifiers: Inhibitors of histone ...
Novel systemic drugs under investigation for the treatment of psoriasis ...
CN1732263A - Genes and proteins for the biosynthesis of the ...
Figure 1 from Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Modeling ...
Phytotherapy Research | Medicinal Chemistry Journal | Wiley Online Library
LY3202626
Pretargeted Alpha Therapy of Disseminated Cancer Combining Click ...
Figure 2 from Structural Analysis of Flavonoid/Drug Target Complexes ...
Schematic representation of the mechanism of action of the ...
Promising Antibiofilm Activity of Peptidomimetics - PMC
:%0A%0ALY3972406%20Dose%202%20for%20Plaque%20Psoriasis.png?md=1)
32549-6/asset/3c466585-b798-4107-8696-b76848558661/main.assets/gr4.jpg)
39139-6/asset/8749b13c-8d55-440a-bbbd-678b94d6890f/main.assets/gr8_lrg.jpg)
12191-8/asset/7efa0ec4-326f-4fdf-9879-385abb0c5f64/main.assets/gr1_lrg.jpg)
